Biologics

Orthobiologics piqued the interest of spine surgeons and Becker's readers in 2024. Here are four key conversations.

Durham, N.C.-based Duke University has won a $3.9 million grant to study gender differences in ACL injuries, according to a Dec. 20 report from WRAL News.

Columbus, Ohio-based Atreon Orthopedics has completed 10,000 rotator cuff repair surgeries with the use of its Rotium bioresorbable wick. 

RTI Surgical, a contract development and manufacturing organization for regenerative medicine, rebranded to Evergen.

A clinical trial out of the University of California San Diego School of Medicine found that neural stem cell transplantation had shown long-term safety and feasibility for treating chronic spinal cord injuries.

Theradaptive earned the FDA's investigational device exemption approval to broaden its clinical research for the OsteoAdapt SP implant, the company said Dec. 10.

Three-year data for the Discseel spine procedure found it was effective and could replace most spine surgeries, Discseel Technologies said Dec. 4. 

Bioretec signed a distribution agreement to accelerate commercialization of the RemeOs trauma screw system in the U.S., according to a Nov. 22 news release. 

From company acquisitions to FDA nods, here are six key updates in orthobiologics since Oct. 4.

Acuitive Technologies earned FDA clearance for the Citrepore bioactive bone filler, the company said Nov. 12.